ArticleJACC. Case reports2026
Inflammatory Pericardial Effusion With Hemorrhagic Conversion in Takotsubo Cardiomyopathy.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTakotsubo cardiomyopathy (TC) is a reversible stress-induced cardiomyopathy that may be triggered by acute neurologic events. Significant pericardial effusions associated with TC are uncommon, and hemorrhagic transformation is rarely reported. CASE SUMMARY: A 75-year-old woman developed TC after an ischemic stroke and was started on dual antiplatelet therapy (DAPT). Initial transthoracic echocardiogram demonstrated a small pericardial effusion. Six weeks later, she was incidentally found to have a large hemorrhagic pericardial effusion with echocardiographic features of tamponade requiring pericardiocentesis and ultimately a pericardial window. Extensive evaluation for infectious, malignant, and autoimmune etiologies was unrevealing. DISCUSSION: This case highlights a rare progression from TC-associated inflammatory pericardial effusion to a hemorrhagic effusion in the setting of recent DAPT exposure and underscores the complex interaction between neurocardiac stress and bleeding risk. TC may generate an inflammatory milieu involving the pericardium and pleura, increasing the risk of effusions and influencing management, particularly with antithrombotic therapy. TAKE-HOME MESSAGES: TC after acute neurologic injury can be complicated by evolving pericardial effusions that may rarely become hemorrhagic. In patients receiving DAPT, close surveillance may be warranted, as antithrombotic exposure may potentiate clinically significant pericardial bleeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.